Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Argyrios Ginoudis has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association Between Vitamin B12, Folate, and Erythrocyte Indices in Cats: A Retrospective Study

    by Argyrios Ginoudis, Dimitra Giota, Dimitrios Galiatsatos, Zoe Polizopoulou, Alexandros Konstantinidis, Dimitra Pardali

    Background/Objectives: Vitamin B12 (cobalamin) and folate deficiencies are classically associated with impaired DNA synthesis and megaloblastic erythropoiesis, but their hematologic expression in cats remains incompletely characterized. This exploratory retrospective study evaluated associations between serum cobalamin and folate concentrations and routine erythrocyte indices in 88 cats. Methods: Retrospective laboratory data from 88 cats were evaluated. Serum cobalamin and folate measurements were available for subsets of the study population, and each analysis was restricted to observations with the required measurements. Pearson and Spearman correlations were calculated between vitamin concentrations and red blood cell count (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), and reticulocyte count. Erythrocyte variables were also compared between cats classified as having low versus non-low vitamin concentrations using Mann–Whitney tests. The primary analyses used unadjusted two-sided p values and were interpreted as exploratory. Results: The final study population comprised 88 client-owned cats, with serum cobalamin and folate measurements available for 83 and 68 cats, respectively. No statistically significant correlations were identified between serum cobalamin or folate concentrations and the evaluated erythrocyte indices (all p > 0.05). Following the exclusion of observations without the relevant serum vitamin measurement, no statistically significant differences were observed between low- and non-low-vitamin groups. MCV was numerically lower in cats with low folate concentrations (median 47.0 vs. 48.1 fL), although the difference was small (1.1 fL) and not statistically significant (p = 0.071). These exploratory findings should be interpreted cautiously because of multiple comparisons and limited subgroup sizes. Conclusions: In this retrospective feline population, routine erythrocyte indices showed weak and statistically non-significant associations with serum cobalamin and folate concentrations. These findings suggest that normal erythrocyte indices alone should not be used to exclude low serum vitamin concentrations. Prospective studies incorporating functional biomarkers and diagnostic performance analyses are needed before definitive conclusions can be drawn regarding the clinical utility of CBC indices for identifying vitamin abnormalities.

  • Open Access

    Longitudinal and Machine-Learning Analysis of Concentration-Dependent Clinicopathologic Changes During Phenobarbital Treatment in Dogs

    by Argyrios Ginoudis, Dimitris Galiatsatos, Rania D. Baka, Dimitra Pardali, Anna Tiagou, Zoe Polizopoulou

    Phenobarbital (PB) is widely used for long-term management of canine epilepsy, but treatment may alter hepatic biochemical variables and, less commonly, cause idiosyncratic hematological reactions. This retrospective observational repeated-measure study evaluated associations between serum PB concentration and concurrent hepatic and hematological findings and explored their predictive value. The dataset comprised 233 laboratory visits from 67 dogs. Repeated-measures generalized estimating equations, within-dog and longitudinal analyses, receiver operating characteristic analyses, and dog-grouped machine-learning models were applied. Serum PB concentration showed its clearest association with alkaline phosphatase (ALP). Each 10 μg/mL increase in PB was associated with a 37.6% increase in ALP activity (95% confidence interval [CI], 11.6–69.7%; p = 0.0028); after adjustment for age, sex, neutering status, and diagnostic category, the increase was 34.9% (95% CI, 10.2–65.0%; p = 0.0036) and remained significant after false-discovery-rate correction. No comparable concentration-dependent relationship was identified for the principal hematological outcomes. A PB concentration > 30 μg/mL was relatively specific but poorly sensitive for hepatic biochemical abnormalities, and machine-learning models showed only modest or poor discrimination. Serum PB concentration should therefore be interpreted together with serial biochemical and hematological measurements rather than as a stand-alone indicator of treatment safety.

  • Open Access

    Serum Redox Biomarkers in Canine Mast Cell Tumors: Exploratory Associations with Proliferative Activity and Clinicopathological Features

    by Argyrios Ginoudis, Dimitra Pardali, Mathios E. Mylonakis, Serafeim Chaintoutis, Dimitris Galiatsatos, Angelos-Lauris Thomas, Zoe Polizopoulou

    Canine mast cell tumors (MCTs) exhibit heterogeneous biological behavior and provide a clinically relevant setting in which relationships between tumor phenotype and systemic redox homeostasis can be investigated. This exploratory prospective cohort study evaluated complementary circulating redox-related biomarkers representing hydroperoxide-derived oxidant products, antioxidant capacity, lipid peroxidation-related products, and oxidative DNA damage, and examined their associations with clinicopathological features of canine MCTs. Sixty-seven dogs with cytologically and histologically confirmed cutaneous or subcutaneous MCTs were included. Clinical staging was performed using cytological evaluation of lymph nodes, liver and spleen, and excised tumors were classified according to the Patnaik and Kiupel systems. Proliferative activity was assessed using Ki-67, and surgically excised lymph nodes were classified according to the Weishaar HN system. Serum reactive oxygen metabolites (d-ROMs), malondialdehyde (MDA), 8-hydroxy-2′-deoxyguanosine (8-OHdG) and antioxidant capacity using the OXY-adsorbent test were measured before therapeutic intervention. In the unadjusted analysis, serum MDA concentrations were higher in dogs with Ki-67 >23 than in dogs with Ki-67 ≤23 (median 10.8 vs. 7.0 μmol/L; raw p = 0.0254); however, this comparison did not remain statistically significant after Bonferroni correction for the 12 formal inferential biomarker × clinicopathological comparisons (adjusted p = 0.3052). The estimated Hodges–Lehmann location shift was +3.00 μmol/L (unadjusted bootstrap 95% CI, 0.58–6.00). No evaluated biomarker–clinicopathological association remained statistically significant after multiplicity adjustment. The observed MDA–Ki-67 pattern should therefore be regarded as exploratory and hypothesis-generating rather than as evidence of established prognostic or clinical utility. Long-term data on recurrence, progression, and survival were not available; therefore, prognostic utility could not be evaluated. Larger prospective studies incorporating longitudinal outcomes are warranted.

  • Open Access

    Machine Learning-Based Classification of Glycemic Status Using Routine Laboratory Data: A Comparative Study of Statistical and Ensemble Models

    by Argyrios Ginoudis, Dimitra Pardali, Eleni Vagdatli, Evgenia Lymperaki, Dimitrios Galiatsatos

    Early identification of individuals with abnormal glucose metabolism is essential for timely intervention and prevention of diabetes-related complications. Routine laboratory testing generates large amounts of clinical data that may support automated glycemic classification through machine learning approaches. This study aimed to develop and evaluate a machine learning framework for the classification of HbA1c-defined glycemic status using routinely available clinical laboratory features. A retrospective dataset of 1434 individuals with available glycemic measurements was analyzed. Participants were categorized into HbA1c-defined normoglycemic, prediabetic-range, or diabetic-range groups. Three concurrent classification tasks were examined: HbA1c-defined dysglycemia classification, diabetic-range HbA1c classification, and multiclass HbA1c-defined glycemic-status classification. Demographic, biochemical, and hematological variables were used as predictors. Data preprocessing included missing-value handling, feature filtering, and outlier treatment. Several supervised learning algorithms were evaluated, including Logistic Regression, Random Forest, Gradient Boosting, Support Vector Machine, and Multinomial Logistic Regression. Model performance was assessed using train–test validation and cross-validation with accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve. For dysglycemia, Gradient Boosting achieved the highest AUC (0.848), while Random Forest achieved the highest accuracy (0.801) and sensitivity (0.908). For diabetic-range HbA1c, Random Forest achieved the highest AUC (0.864), whereas SVM achieved the highest accuracy (0.794). In multiclass classification, Random Forest achieved the highest accuracy (0.610), while Gradient Boosting achieved the highest macro-AUC (0.796) and macro-F1 score (0.603). Pairwise comparisons showed no statistically significant superiority of any classifier after Holm correction. Clinical-baseline and ablation analyses demonstrated that fasting glucose accounted for a substantial proportion of discrimination, with only modest incremental value from additional laboratory variables. These findings support cautious interpretation of routine laboratory-based classification models pending further validation and clinical-utility assessment.


  • Open Access

    Assessment of Pancreatic Lipase Activity Using a Quantitative and a Qualitative Assay in Dogs with Chronic Kidney Disease

    by Dimitra Pardali, Rafailia Karaiosif, Argyrios Ginoudis, Katerina K. Adamama-Moraitou, Zoe Polizopoulou

    Chronic kidney disease (CKD) in dogs is associated with increased serum pancreatic lipase activity, complicating the diagnosis of acute pancreatitis (AP). This prospective study evaluated pancreatic lipase activity measured using a quantitative DGGR assay in dogs with CKD while excluding cases with clinical or imaging evidence of AP, and the DGGR results were compared with the qualitative SNAP cPL test. Twenty-five dogs with IRIS stage 1–4 CKD were enrolled. The DGGR results were within the reference range in 52% of dogs and elevated in 48%, whereas the SNAP cPL results were abnormal in 72% of cases. Discordance between tests was common, with several dogs showing abnormal SNAP cPL results despite normal DGGR values, a difference that was statistically significant (p = 0.016). The DGGR results revealed significant differences between normal and abnormal values relative to serum creatinine and blood urea nitrogen concentration, as well as total serum lipase activity, suggesting an influence of impaired renal function on pancreatic lipase. No significant association was observed between CKD stage and either DGGR or SNAP cPL results. These findings indicate that pancreatic lipase activity may be increased in dogs with CKD independently of AP and that SNAP cPL may overestimate pancreatic enzyme elevation in this population. DGGR appears to be more reliable for excluding AP in dogs with CKD, although positive results should be interpreted cautiously in conjunction with clinical and imaging findings.

  • Open Access

    Assessment of Oxidative Stress-Related Markers and Inflammatory Proteins in Serum and CSF Samples of Dogs with Different Types of Epilepsy

    by Rania D. Baka, Argyrios Ginoudis, Maria Botia, Juan Diego Garcia-Martinez, Ioannis Savvas, Dimitra Giota, Zoe Polizopoulou

    Background: Oxidative stress contributes to the development and progression of epilepsy and is connected with neuroinflammation during epileptic seizures. Cholinesterase has a modulatory role, and oxytocin has antiepileptic properties. The purpose of this study was to assess selective inflammatory (C-Reactive Protein, CRP) and oxidative stress markers [Paraoxonase-1 (PON1), cupric reducing antioxidant capacity (CUPRAC), ferric reducing antioxidant power (FRAP), cholinesterase, and oxytocin in serum and cerebrospinal fluid (CSF) samples of dogs with different types of epilepsy. Methods: There were four groups of dogs; A: healthy controls; B: idiopathic epilepsy receiving antiepileptic medication; C: idiopathic epilepsy without antiepileptic medication; and D: structural epilepsy. CRP, PON1, CUPRAC, and cholinesterase were evaluated in serum and PON1, CUPRAC, FRAP, cholinesterase and oxytocin were evaluated in CSF samples. Group differences were evaluated using the ANOVA test, followed by post hoc analyses or Kruskal–Wallis/Dunn’s test. Results: Fifty-one serum and 26 CSF samples were analyzed. CSF PON1 was significantly different in group D compared with groups A and C (p = 0.044 and p = 0.008, respectively). CSF cholinesterase was significantly different in group D compared with groups A, B and C (p = 0.003, p = 0.025, and p = 0.033, respectively). Conclusions: Structural epilepsy may influence PON1 and cholinesterase levels in CSF samples. Compared with CSF, serum was not the most suitable biological material to investigate oxidative stress and inflammatory markers.


  • Open Access

    Assessment of Oxidative Stress-Related Markers and Inflammatory Proteins in Serum and CSF Samples of Dogs with Different Types of Epilepsy

    by Rania D. Baka, Argyrios Ginoudis, María Botía, Juan Diego Garcia-Martinez, Ioannis Savvas, Dimitra Giota, Zoe Polizopoulou

    Background: Oxidative stress contributes to the development and progression of epilepsy and is connected with neuroinflammation during epileptic seizures. Cholinesterase has a modulatory role, and oxytocin has antiepileptic properties. The purpose of this study was to assess selective inflammatory (CRP) and oxidative stress markers (PON1, CUPRAC, FRAP), cholinesterase, and oxytocin in serum and CSF samples of dogs with different types of epilepsy. Methods: There were four groups of dogs; A: healthy controls; B: idiopathic epilepsy receiving antiepileptic medication; C: idiopathic epilepsy without antiepileptic medication; and D: structural epilepsy. CRP, PON1, CUPRAC, and cholinesterase were evaluated in serum and PON1, CUPRAC, FRAP, cholinesterase and oxytocin were evaluated in CSF samples. Group differences were evaluated using ANOVA or Kruskal–Wallis tests, followed by post-hoc analyses. Results: Fifty-one serum and 26 CSF samples were analyzed. CSF PON1 was significantly different in group D compared to groups A and C (p=0.044 and p=0.008, respectively). CSF cholinesterase was significantly different in group D compared to groups A, B and C (p=0.003, p=0.025, p=0.033, respectively). Conclusions: Structural epilepsy may influence PON1, CUPRAC and cholinesterase levels in CSF samples. Compared to CSF, serum was not the most suitable biological material to investigate oxidative stress and inflammatory markers.

  • Open Access

    Successful Management of a Pancreatic Abscess in a Dog with Juvenile Diabetes Mellitus Through Ultrasound-Guided Drainage and Medical Therapy

    by Alexandra Daravigka, Stefanos Ninis, Panagiotis Bourdekas, Alexandros O. Konstantinidis, Argyrios Ginoudis, Katerina K. Adamama-Moraitou, Maria Lyraki, Nektarios Soubasis

    A five-month-old female mixed-breed dog presented with a two-week history of polyuria, polydipsia, and vomiting. Clinical examination revealed poor body condition, growth retardation, pale oral mucous membranes, weak pulse, and prolonged capillary refill time. Laboratory findings included neutrophilic leukocytosis with a regenerative left shift, fasting hyperglycemia, elevated fructosamine, glycated hemoglobin, and β-hydroxybutyrate concentrations, while the acid–base balance remained normal. Canine-specific pancreatic lipase and trypsin-like immunoreactivity concentrations ruled out an underlying pancreatitis or exocrine pancreatic insufficiency, respectively. Urinalysis showed glycosuria and ketonuria. Supportive care included antibiotics and regular insulin administration. Abdominal ultrasonography identified a pancreatic cavity with a thick wall and mixed echogenic fluid. Ultrasound-guided drainage was performed without complications. Cytology confirmed a pancreatic abscess with pyogranulomatous inflammation, though the culture results were negative. The dog was discharged with intermediate-acting lente insulin. Follow-up ultrasonographic evaluations at 7, 14, and 21 days and 5 months post-drainage showed no recurrence. The diabetes remained well-controlled one year post-discharge. This case report describes the successful management of a dog with juvenile diabetes mellitus complicated by a pancreatic abscess, highlighting the effectiveness of percutaneous ultrasound-guided drainage combined with medical therapy.

  • Open Access

    Study of Oxidant/Antioxidant Profile in Dogs with Mammary Cancer Undergoing Mastectomy, During the Peri-Operative Period

    by Angelos-Lauris Thomas, Maria Karayannopoulou, Tilemachos Anagnostou, Dimitra Psalla, Konstantinos Ioannou, Argyrios Ginoudis, Ioannis Savvas, Dimitra Pardali

    In cancer cases, any imbalance between Reactive Oxygen Species (ROS) production and host antioxidant capacity (oxidative stress), during the immediate post-operative period, is involved in cancer cell dissemination (micro-metastases). Surgical trauma is considered the main cause for ROS production during that period. Increased oxidative stress has been found in dogs with mammary neoplasms. Our objective was to investigate the blood oxidant/antioxidant profile in bitches with mammary cancer, during the peri-operative period, hypothesizing that oxidative stress would be further increased after mastectomy. Twelve bitches with mammary cancer and no distant metastases, with a comparable extent of surgical wound and receiving the same anesthetic protocol, were included. Their serum oxidant/antioxidant profile was evaluated chromatometrically using the d-ROMs (Reactive Oxygen Metabolite-derived compounds) and the BAP (biological antioxidant potential) tests, on the 1st day (before/after surgery), and on the 2nd, 3rd and 10th days post-operatively. The ratio of d-ROMs and BAP values (oxidative stress index; OSI) was also calculated. Statistically significant differences (increases) were found only in d-ROMS on the second and third post-operative day compared to the first day (before surgery) of measurement (p = 0.007 and p = 0.002, respectively). Our findings indicate a post-surgical overproduction of ROS and therefore an oxidative stress increase potentially affecting patient outcome.


  • Open Access

    Oxidative Stress Biomarkers as Preclinical Markers of Mild Cognitive Impairment: The Impact of Age and Sex

    by Stavroula Ioannidou, Magda Tsolaki, Argyrios Ginoudis, Androniki Tamvakis, Anthoula Tsolaki, Kali Makedou, Evgenia Lymperaki

    Background: Reactive oxygen species (ROS) are involved in the pathophysiology of neurodegeneration and cognitive decline, indicating the potential use of oxidative stress biomarkers for early diagnosis. Mild cognitive impairment (MCI) is defined as a cognitive decline beyond normal aging, without significant impact on daily functioning, and is considered an important stage of early detection of neurodegeneration. This study aimed to investigate serum and cerebrospinal fluid (CSF) levels of oxidative stress biomarkers, total ROS and malondialdehyde (MDA) in patients with MCI to evaluate their utility in the early diagnosis of Alzheimer’s disease (AD). Levels of oxidative stress biomarkers were also assessed according to age and sex, as well as their correlation with the established CSF biomarkers, including amyloid-beta (Aβ40, Aβ42 and Aβ42/Aβ40 ratio), phosphorylated tau protein (p-tau) and total tau (t-tau). Methods: A total of 114 adults were divided into three groups: MCI (A−) patients with a normal CSF Aβ42/Aβ40 ratio (n = 38), MCI (A+) patients with an abnormal Aβ42/Aβ40 ratio (n = 38) and healthy cognitive function individuals with a normal Aβ42/Aβ40 ratio (n = 38). Established CSF biomarkers were conducted using an automated immunochemical method, while total ROS levels were measured by fluorometry and MDA levels were determined by competitive inhibition enzyme immunoassay. Results: A statistically significant difference was observed in CSF MDA levels (p < 0.05) and serum ROS levels (p < 0.05) between the study groups. Sex analysis revealed significantly higher levels of CSF MDA levels in the MCI (A+) males’ group (p < 0.05). In terms of age categorization, serum MDA levels were markedly higher in the MCI (A+) group of older patients (p < 0.01). Conclusions: These findings highlight the importance of individualized approaches, including investigation of oxidative stress biomarkers profile to prevent and manage individuals in the early stages of MCI, considering demographic factors.